NCT04763122

Brief Summary

The main objective of the study is to assess the trend of clinicopathological features and treatment modalities in patients with thyroid cancer in the largest oncology center in the United Arab Emirates (UAE).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
762

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
Last Updated

February 21, 2021

Status Verified

February 1, 2021

Enrollment Period

10.3 years

First QC Date

February 9, 2021

Last Update Submit

February 17, 2021

Conditions

ThyroidCancer

Keywords

MalignancyRadioactive iodinetotal thyroidectomyThyroid Cancer

Outcome Measures

Primary Outcomes (3)

  • Clinicopathological features

    Assess clinicopathological features of thyroid cancer patients

    September 2008- December 2018

  • Extent of surgery

    Assess extent of surgery in thyroid cancer patients and changes over time

    September 2008- December 2018

  • Use of RAI

    Evaluate the use of RAI in thyroid cancer patients and assess predictors of RAI Rx

    September 2008- December 2018

Study Arms (1)

Thyroid Cancer Cases

Other: not applicable as it is a retrospective study

Interventions

not applicable as it is a retrospective studyOTHER

It is a retrospective study

Thyroid Cancer Cases

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with Thyroid Cancer presenting to Tawam Hospital during the period of September 2008 and December 2018. Those with incorrect pathological diagnosis, incomplete data, or noninvasive follicular type PTC were excluded.

You may qualify if:

  • All patients with Thyroid Cancer presenting to Tawam Hospital during the period of September 2008 and December 2018.

You may not qualify if:

  • Patients with inadequate data, noninvasive follicular type PTC and incorrect pathological diagnosis,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Thyroid DiseasesNeoplasmsThyroid Neoplasms

Condition Hierarchy (Ancestors)

Endocrine System DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteHead and Neck Neoplasms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Endocrinologist

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 21, 2021

Study Start

September 1, 2008

Primary Completion

December 1, 2018

Study Completion

December 1, 2020

Last Updated

February 21, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share